Project Grant HT94252310153
Award Date
3/15/23
Completion Date
3/14/26
Dollars Obligated
$2.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
The University of California, Davis (UC Davis) has been awarded a $1,000,000 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) for the "THE GOOD LIFE HEALTHY AGING PROGRAM TO PREVENT COGNITIVE IMPAIRMENT IN DIVERSE VETERAN COMMUNITIES: AN EMBEDDED PRAGMATIC CLINICAL TRIAL". The grant, which runs from May 1, 2024 to April 30, 2027, will fund research aimed at improving health outcomes for...
The University of California, San Diego will receive $790,000 under a two-year Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Catalog of Federal Domestic Assistance number 12.420. The university will conduct research on neuron-targeted caveolin gene therapy as a potential route of administration to treat amyotrophic lateral sclerosis. Specifically, the funding will...
This federal Project Grant award of $321,981.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of California, Davis focused on sensory processing contributions to emotion dysregulation and internalizing problems in autism. The award, which runs from April 1, 2025 to March 31, 2027, will fund advanced biomedical research initiatives to investigate innovative approaches to disease prevention,...
This federal Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), provides $963,000.00 to The Regents of the University of California, doing business as University of California, Berkeley, to conduct research on "REBALANCING C9ORF72 LOSS OF FUNCTION IN AMYOTROPHIC LATERAL SCLEROSIS". The research, which will take place over a two-year period from March 1, 2024 to February 28, 2026, aims to...
The Department of the Army Medical Command awarded a $1,180,437 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports UCLA's research to evaluate circulating cell-free DNA as a biomarker for diagnosing and tracking the progression of amyotrophic lateral sclerosis (ALS). The award began on March 1, 2024 and is scheduled for completion by February 28, 2026. Through this Project Grant, UCLA...
The University of California, Davis was awarded a $1,298,836 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. Specifically, the research aims to investigate the toxic products of combustion in burn and smoke inhalation injuries. The 3-year grant, awarded on November 1,...
The University of California, Davis was awarded a $1,446,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on "THERAPEUTIC TARGETING OF A NOVEL TUMOR-INTRINSIC SIGNALING PATHWAY FOR LETHAL PROSTATE CANCER." The award period is from August 1, 2023 to July 31, 2026. UC Davis will leverage its expertise in medical research to investigate potential medical solutions relevant to the...
This federal Project Grant award, with an ID of HT94252510188, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The $1,181,251 grant, awarded on April 15, 2025, supports the University of California, Los Angeles (UCLA) in conducting research on "Neuronal Exosome-Based Biomarkers for ALS Diagnosis and Disease Progression." The project aims to develop novel biomarkers derived from neuronal exosomes to enhance the...
The University of California, San Diego received a $694,650 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award will support research on RNA-directed therapy for amyotrophic lateral sclerosis (ALS) linked to the C9ORF72 gene using engineered zinc finger nucleases. The Military Medical Research and Development program aims to transform military and public health through...
The University of California, San Diego (UCSD) was awarded a $2,179,391 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct proof-of-concept preclinical studies and GMP development of AAV-SynCav1 gene technology to treat amyotrophic lateral sclerosis (ALS). The award, which began on May 1, 2024, will support research and development efforts aimed at advancing a novel gene therapy approach to address this debilitating...